METFIG L 2.5/500 TABLET

Product Description

Product Name: METFIG L 2.5/500 TABLETComposition: Linagliptin 2.5 mg + Metformin 500 mgProduct Description: METFIG L 2.5/500 TABLET is a combination anti-diabetic medication that offers dual-action control for patients with Type 2 Diabetes Mellitus. Each tablet blends Linagliptin (2.5 mg), a DPP-4 inhibitor, with Metformin (500 mg), a time-tested biguanide, to improve glycemic control by enhancing insulin secretion and reducing hepatic glucose production.This fixed-dose combination is ideal for patients who require a convenient and effective oral therapy to manage blood sugar levels alongside lifestyle modifications.Key Benefits: Dual mechanism of action: Improves insulin sensitivity and secretion Effective HbA1c reduction in Type 2 diabetic patients Low risk of hypoglycemia and weight neutrality Convenient dosing improves compliance and treatment adherence Trusted combination widely prescribed by endocrinologists and diabetologists Usage: Indicated for adults with Type 2 Diabetes Mellitus when diet and exercise alone do not provide adequate glycemic control. Can be used as monotherapy or in combination with other antidiabetic agents as directed by a physician.Target Audience: Pharmaceutical wholesalers, hospital pharmacies, diabetic care clinics, B2B medicine resellers, and bulk drug suppliers seeking high-demand anti-diabetic formulations with proven clinical efficacy. Add METFIG L 2.5/500 TABLET to your pharma portfolio a reliable and effective solution for modern diabetes management.Connect with us for bulk orders, distributor pricing, and partnership opportunities.